Orum Therapeutics (XKRX:475830) EPS (Basic): ₩-2,261.00 (TTM As of Mar. 2026)


XKRX:475830 Orum Therapeutics Inc XKRX:475830
7 GF Score
Price ₩49,300.00
! 2 Warning Signs
View Full Analysis

What is Orum Therapeutics EPS (Basic)?

Orum Therapeutics XKRX:475830 -5.74% 7 EPS (Basic) is ₩-2,261.00 as of Mar. 2026. GuruFocus rates XKRX:475830 with a GF Score™ of 7/100. The stock has 2 warning signs investors should review.

Orum Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₩-677.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₩-2,261.00.

Orum Therapeutics's EPS (Diluted) for the three months ended in Mar. 2026 was ₩-677.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₩-2,261.00.

Orum Therapeutics's EPS without NRI for the three months ended in Mar. 2026 was ₩-761.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -2,446.08.

During the past 3 years, the average EPS without NRI Growth Rate was 46.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Orum Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 46.10% per year. The lowest was 46.10% per year. And the median was 46.10% per year.

Orum Therapeutics  (XKRX:475830) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Orum Therapeutics EPS (Basic) Related Terms

Orum Therapeutics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Orum Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orum Therapeutics EPS (Basic) Chart

Orum Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS (Basic)
-13,765.00 14,830.00 -424.00 -2,017.00

Orum Therapeutics Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -433.00 -179.00 -646.00 -759.00 -677.00
XKRX:475830
7GF Score
Orum Therapeutics Inc XKRX:475830
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orum Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Orum Therapeutics's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-41969.172-0)/20.808
=-2,016.97

Orum Therapeutics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-15278.008-0)/22.578
=-676.68

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,261.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₩-2,261.00 mean?
Orum Therapeutics (XKRX:475830) has a EPS (Basic) of ₩-2,261.00 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Orum Therapeutics and its competitors.
Is Orum Therapeutics' EPS (Basic) too high?
Orum Therapeutics' current EPS (Basic) is ₩-2,261.00. Overall, Orum Therapeutics has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Orum Therapeutics' EPS (Basic) compare to VRTX and REGN?
Orum Therapeutics' EPS (Basic) of ₩-2,261.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Orum Therapeutics and its competitors. Orum Therapeutics's current EPS (Basic) is ₩-2,261.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orum Therapeutics stock overvalued right now?
Orum Therapeutics (XKRX:475830) has a current EPS (Basic) of ₩-2,261.00. The current EPS (Basic) is ₩-2,261.00. Orum Therapeutics' overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Orum Therapeutics (XKRX:475830), the current EPS (Basic) is ₩-2,261.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orum Therapeutics Business Description

Address Munji-ro, 281-25, 2nd floor, Yuseong-gu, Munji-dong, Daejeon, KOR
Orum Therapeutics Inc is a biotechnology company that develops anticancer drugs with the technology to attach novel drug payloads to ADC. It can develop all three components of ADC, which consist of antibodies, payloads, and linkers, in-house. The group pioneering a class of therapeutics intended to expand the universe of druggable targets and to meaningfully improve upon potency and tolerability, thereby improving the therapeutic window of drugs. Its services include the modeling, research, development, and testing of pharmaceuticals and treatments for such diseases for Orum's partners and licensees. The pipeline products are TPD2GSPT1, TPD2PROTAb, and TPS2Cbl-b.
7GF Score

Get the complete analysis for XKRX:475830

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩49,300.00
Price